Breast Diseases  >>  Ogsiveo (nirogacestat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ogsiveo (nirogacestat) / SpringWorks Therap
NCT02299635 / 2014-002286-30: A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations

Terminated
2
19
US, Europe
PF-03084014
Pfizer
Triple Negative Breast Neoplasms
01/16
01/16
RHEA, NCT02338531 / 2014-004358-32: Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer

Withdrawn
2
0
Europe
PF-03084014, Breast cancer surgery
Jules Bordet Institute
Breast Cancer
09/18
12/18

Download Options